Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Infections × Observation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Oropharyngeal Neoplasms 2 Multiple Myeloma 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Retinoblastoma 1 Recurrence 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Osteoporosis 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Lymphoma, Mantle-Cell 1

Interventions

telavancin 1 monalizumab 1 fludarabine phosphate 1 fish oil triglycerides 1 avdoralimab 1 Whole-Body Irradiation 1 Voriconazole 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Therapeutics 1 Tacrolimus 1 Standard of Care 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Observation 1 Methotrexate 1 Melphalan 1 Interferon-gamma 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Daptomycin 1 Cyclophosphamide 1 Clarithromycin 1 Caspofungin 1 Bevacizumab 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02624440 2015-12-08

SUTRICA

Aalborg University Hospital

Phase 2 Unknown

Infections, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡